BIO welcomes advances in stem cell research.

Press Release Summary:



Through induced pluripotent stem cell technique, researchers at Harvard Stem Cell Institute created 20 disease-specific stem cell lines. BIO President and CEO, Jim Greenwood commended Institute for their research and for making stem cell lines available to researchers worldwide. According to Greenwood, we must do all we can to accelerate research and explore all avenues of therapeutic possibilities to their fullest to determine which areas can present treatment options fastest.



Original Press Release:



BIO Welcomes Advances in Stem Cell Research



Stresses Continued Importance of Pursuing All Promising Areas of Research

Contact:

Contact Stephanie Fischer

(202) 312-9263

WASHINGTON, D.C. (Friday, August 08, 2008) - BIO President and CEO Jim Greenwood issued the following statement regarding the news that researchers at the Harvard Stem Cell Institute created 20 disease-specific stem cell lines thru the new induced pluripotent stem cell (iPS) technique:

"The creation of stem cells lines carrying the genes or genetic components of ten diseases is a great step forward in the quest to understand, treat and eventually cure disease. We commend the Institute for their research and for making these stem cell lines available to researchers around the world to study.

"As the researchers have noted, while these stem cell lines were created thru iPS, we should not abandon other promising areas of research such as embryonic stem cell research. We must do all we can to accelerate research and explore all avenues of therapeutic possibilities to their fullest to determine which areas can present treatment options fastest.

"BIO will continue to support and advocate for increased funding for all promising areas of therapeutic research."

Upcoming BIO Events

Pacific Rim Summit on Industrial Biotechnology and Bioenergy

Sept. 10-12, 2008

Vancouver, BC, Canada

Intellectual Property Council Committee Fall Conference and Meeting

October 20-22, 2008

Orlando, Fla.

BIO HR Conference 2008

October 26-28, 2008

San Diego, Calif.

Advanced Business Development Course

October 27-29, 2008

San Francisco, Calif.

BIO Investor Forum 2008

October 29-31, 2008

San Francisco, Calif.

Advanced Business Development Course

November 14-16, 2008

Mannheim/Heidelberg, Germany

BIO-Europe 2008

November 17-19, 2008

Mannheim/Heidelberg, Germany

2009 BIO International Convention

May 18-21, 2009

Atlanta, Ga.

About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

All Topics